Synthace, the life sciences software company today announced it raised $35 million in Series C funding. The investment will fuel commercial and go-to-market growth as Synthace continues to radically reinvent the full value chain of life sciences R&D. The company also plans to expand its senior leadership team in the U.S., with new vice presidents of marketing and sales joining the U.S.-based CEO. Source: Synthace press release 16/11/2021